Envestnet Asset Management Inc. Purchases 25,680 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT)

Envestnet Asset Management Inc. lifted its stake in shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) by 9.9% in the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 285,109 shares of the medical instruments supplier's stock after purchasing an additional 25,680 shares during the period. Envestnet Asset Management Inc. owned 1.26% of LeMaitre Vascular worth $23,921,000 at the end of the most recent quarter.

Several other large investors also recently modified their holdings of LMAT. Raymond James Financial Inc. purchased a new stake in shares of LeMaitre Vascular during the 4th quarter worth approximately $14,900,000. Rockefeller Capital Management L.P. purchased a new position in LeMaitre Vascular in the 4th quarter valued at approximately $7,787,000. Segall Bryant & Hamill LLC purchased a new position in LeMaitre Vascular in the 4th quarter valued at approximately $5,446,000. Invesco Ltd. grew its stake in LeMaitre Vascular by 50.5% in the 4th quarter. Invesco Ltd. now owns 174,998 shares of the medical instruments supplier's stock valued at $16,124,000 after buying an additional 58,720 shares in the last quarter. Finally, GAMMA Investing LLC grew its stake in LeMaitre Vascular by 7,486.5% in the 1st quarter. GAMMA Investing LLC now owns 53,864 shares of the medical instruments supplier's stock valued at $4,519,000 after buying an additional 53,154 shares in the last quarter. Hedge funds and other institutional investors own 84.64% of the company's stock.

LeMaitre Vascular Stock Performance

LeMaitre Vascular stock traded down $0.89 during mid-day trading on Thursday, reaching $81.73. The company's stock had a trading volume of 42,389 shares, compared to its average volume of 192,665. LeMaitre Vascular, Inc. has a 12-month low of $71.42 and a 12-month high of $109.58. The company has a market capitalization of $1.85 billion, a P/E ratio of 41.28, a PEG ratio of 2.17 and a beta of 0.82. The company has a debt-to-equity ratio of 0.48, a quick ratio of 13.83 and a current ratio of 16.49. The firm's fifty day moving average price is $82.81 and its two-hundred day moving average price is $87.93.

LeMaitre Vascular (NASDAQ:LMAT - Get Free Report) last released its quarterly earnings data on Thursday, May 1st. The medical instruments supplier reported $0.48 earnings per share for the quarter, missing analysts' consensus estimates of $0.50 by ($0.02). LeMaitre Vascular had a net margin of 19.96% and a return on equity of 13.53%. The business had revenue of $59.87 million during the quarter, compared to analysts' expectations of $57.61 million. During the same quarter in the prior year, the firm posted $0.44 earnings per share. The firm's quarterly revenue was up 12.0% on a year-over-year basis. Sell-side analysts predict that LeMaitre Vascular, Inc. will post 1.94 EPS for the current fiscal year.

LeMaitre Vascular Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Thursday, May 29th. Shareholders of record on Thursday, May 15th were issued a $0.20 dividend. This represents a $0.80 annualized dividend and a yield of 0.98%. The ex-dividend date of this dividend was Thursday, May 15th. LeMaitre Vascular's payout ratio is 40.40%.

Insider Buying and Selling

In other LeMaitre Vascular news, CEO George W. Lemaitre sold 76,868 shares of the firm's stock in a transaction on Monday, May 19th. The shares were sold at an average price of $85.79, for a total value of $6,594,505.72. Following the completion of the transaction, the chief executive officer directly owned 1,796,783 shares of the company's stock, valued at $154,146,013.57. This trade represents a 4.10% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Over the last ninety days, insiders have sold 100,000 shares of company stock valued at $8,556,857. 9.50% of the stock is owned by company insiders.

About LeMaitre Vascular

LeMaitre Vascular, Inc develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature.